References
- Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30(5 Pt l): 774–8
- Boring CC, Squires TS, Tong T, et al. Cancer statistics, 1994. CA Cancer J Clin 1994; 44(l): 7–26
- Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131(2): 157–63
- Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995; 131(2): 164–9
- Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988; 91 (2): 120–4 [Erratum, J Invest Dermatol 1989; 92(2): 300]
- Johnson TM, Rowe DE, Nelson BR, et al. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992: 26(3 Pt 2): 467–84
- Schwartz RA, Stoll HL Jr. Squamous cell carcinoma. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in general medicine. 4th ed. New York: McGraw-Hill, 1993: 821–39
- Carter DM, Lin AN. Basal cell carcinoma. In: Fitzpatrick et al, eds, pp 840–7
- Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992: 327(23): 1649–62
- Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49(3): 506–9
- Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, et al. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 1991; 325(12): 843–8
- Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992: 26(1): 1–26
- Kinlen LJ. Malignancy in autoimmune diseases. J Autoimmun 1992; 5(Suppl A): 363–71
- Weimar VM, Ceilley RI, Goeken JA. Aggressive biologic behavior of basal- and squamous-cell cancers in patients with chronic lymphocytic leukemia or chronic lymphocytic lymphoma. J Dermatol Surg Oncol 1979; 5(8): 609–14
- Kopelson PL, Nguyen QH, Moy RL. Verruca vulgaris and radiation exposure are associated with squamous cell carcinoma of the finger. J Dermatol Surg Oncol 1994; 20(1): 38–41
- Crum CP, Ikenberg H, Richart RM, et al. Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med 1984; 310(14): 880–3
- Clark DP, Feinstein RJ, Graham G. Guidelines of care for actinic keratoses. J Am Acad Dermatol 1995; 32(l): 95–8
- Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992; 26(6): 976–90
- Frierson HF Jr, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol 1986; 17(4): 346–54
- Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15(3): 315–28
- Hruza GJ. Mohs micrographic surgery. Otolaryngol Clin North Am 1990; 23(5): 845–64
- Mohs FE. Chemosurgery: microscopically controlled surgery for skin cancer. Springfield, Ill: Thomas, 1978
- Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15(4): 424–31
- Kraemer KH, DiGiovanna JJ, Moshell AN, et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318(25): 1633–7